Downregulation of Chemokine CCL20 Involved in Myeloma Cells Resistant to Elotuzumab and Lenalidomide

Downregulation of Chemokine CCL20 Involved in Myeloma Cells Resistant to Elotuzumab and Lenalidomide

Huihan Wang, Hua Shi, Xiaowei He, Aijun Liao Haematology Department of Shengjing Hospital, China Medical University, Shenyang, People’s Republic of ChinaCorrespondence: Aijun LiaoHaematology Department of Shengjing Hospital, China Medical University, No. 36 Sanhao Street, Heping District,...

Full description

Bibliographic Details
Main Authors: Wang H, Shi H, He X, Liao A
Format: Article
Language:English
Published: Dove Medical Press 2021-04-01
Series:OncoTargets and Therapy
Subjects:
ccl20
elotuzumab
lenalidomide
drug resistance
multiple myeloma
Online Access:https://www.dovepress.com/downregulation-of-chemokine-ccl20-involved-in-myeloma-cells-resistant--peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/downregulation-of-chemokine-ccl20-involved-in-myeloma-cells-resistant--peer-reviewed-fulltext-article-OTT

Similar Items